IRVINE, Calif., Aug. 3, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the Canaccord Adams 29th Annual Global Growth Conference on Tuesday, August 11, 2009 at The Intercontinental Boston Hotel, in Boston, Massachusetts. The company is scheduled to present at 2:00 p.m. EST.
SenoRx invites investors and those interested to listen to a live webcast of this presentation via the Internet on the Investor Relations section of the company's website at http://investor.senorx.com/events.cfm. A webcast replay of the presentation will be available on the company's website and will be archived for approximately 90 days.
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3605